Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.

Overall, we highlight the link between different genetic events and the immune microenvironment in CRC, taking into consideration the status of microsatellite instability. Our data provide further evidence that MSI+ and CYT-high tumors are better candidates for combinatorial checkpoint inhibition.